Hemophilia C: Difference between revisions

Jump to navigation Jump to search
Aarti Narayan (talk | contribs)
No edit summary
Aarti Narayan (talk | contribs)
No edit summary
Line 21: Line 21:
'''Hemophilia C''' is a mild form of [[haemophilia]] affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common [[coagulation]] disorder after [[von Willebrand's disease]] and [[haemophilia]] [[Haemophilia A|A]] and [[Haemophilia B|B]].
'''Hemophilia C''' is a mild form of [[haemophilia]] affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common [[coagulation]] disorder after [[von Willebrand's disease]] and [[haemophilia]] [[Haemophilia A|A]] and [[Haemophilia B|B]].


It is caused by a deficiency of [[coagulation]] [[factor XI]] and is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints. Furthermore, it has [[autosomal]] recessive inheritance, since the gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency. Treatment is usually not necessary, except in relation to [[Surgery|operation]]s, leading to many of those having the condition not being aware of it. In these cases, [[fresh frozen plasma]] or recombinant factor XI may be used, but only if necessary. The afflicted may often suffer nosebleeds, and females can experience heavy [[menstrual bleeding]]. Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.
==Historical Perspective==
Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.


==Symptoms==
==Pathophysiology==
It is caused by a deficiency of [[coagulation]] [[factor XI]].
 
===Genetics===
It has [[autosomal recessive]] inheritance. The gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency.
 
==Differentiating Hemophilia C from other Diseases==
It is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints.
 
==Diagnosis==
===Symptoms===
The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:
The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:
*Prolonged bleeding from injuries.
*Prolonged bleeding from injuries.
*Frequent or heavy nosebleeds.
*Frequent or heavy nosebleeds.
*Traces of blood in the urine.
*Traces of blood in the urine.
*Females can experience heavy [[menstrual bleeding]]
==Medical Therapy==
Treatment is usually not necessary, except in relation to [[Surgery|operation]]s, leading to many of those having the condition not being aware of it. In these cases, [[fresh frozen plasma]] or recombinant factor XI may be used, but only if necessary.


==See also==
==Related Chapters==
*[[Haemophilia]]
*[[Haemophilia]]
*[[Haemophilia A]]
*[[Haemophilia A]]

Revision as of 15:44, 21 September 2012

Hemophilia C
ICD-10 D68.1
ICD-9 286.2
OMIM 264900
DiseasesDB 29376
MeSH D005173

WikiDoc Resources for Hemophilia C

Articles

Most recent articles on Hemophilia C

Most cited articles on Hemophilia C

Review articles on Hemophilia C

Articles on Hemophilia C in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hemophilia C

Images of Hemophilia C

Photos of Hemophilia C

Podcasts & MP3s on Hemophilia C

Videos on Hemophilia C

Evidence Based Medicine

Cochrane Collaboration on Hemophilia C

Bandolier on Hemophilia C

TRIP on Hemophilia C

Clinical Trials

Ongoing Trials on Hemophilia C at Clinical Trials.gov

Trial results on Hemophilia C

Clinical Trials on Hemophilia C at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hemophilia C

NICE Guidance on Hemophilia C

NHS PRODIGY Guidance

FDA on Hemophilia C

CDC on Hemophilia C

Books

Books on Hemophilia C

News

Hemophilia C in the news

Be alerted to news on Hemophilia C

News trends on Hemophilia C

Commentary

Blogs on Hemophilia C

Definitions

Definitions of Hemophilia C

Patient Resources / Community

Patient resources on Hemophilia C

Discussion groups on Hemophilia C

Patient Handouts on Hemophilia C

Directions to Hospitals Treating Hemophilia C

Risk calculators and risk factors for Hemophilia C

Healthcare Provider Resources

Symptoms of Hemophilia C

Causes & Risk Factors for Hemophilia C

Diagnostic studies for Hemophilia C

Treatment of Hemophilia C

Continuing Medical Education (CME)

CME Programs on Hemophilia C

International

Hemophilia C en Espanol

Hemophilia C en Francais

Business

Hemophilia C in the Marketplace

Patents on Hemophilia C

Experimental / Informatics

List of terms related to Hemophilia C

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Haemophilia type C; haemophilia C; hereditary factor XI deficiency

Overview

Hemophilia C is a mild form of haemophilia affecting both sexes. However, it predominantly occurs in Jews of Ashkenazi descent. It is the fourth most common coagulation disorder after von Willebrand's disease and haemophilia A and B.

Historical Perspective

Hemophaelia C was first discovered in a young Ashkenazic Jewish American in the 1950s.

Pathophysiology

It is caused by a deficiency of coagulation factor XI.

Genetics

It has autosomal recessive inheritance. The gene for factor XI is located on chromosome 4 (close to the prekallikrein gene). Many mutations exist, and the bleeding risk is not always influenced by the severity of the deficiency.

Differentiating Hemophilia C from other Diseases

It is distinguished from haemophilia A and B by the fact it does not lead to bleeding into the joints.

Diagnosis

Symptoms

The symptoms of Haemophilia C are the same as those for other forms of Haemophilia, mainly:

  • Prolonged bleeding from injuries.
  • Frequent or heavy nosebleeds.
  • Traces of blood in the urine.
  • Females can experience heavy menstrual bleeding

Medical Therapy

Treatment is usually not necessary, except in relation to operations, leading to many of those having the condition not being aware of it. In these cases, fresh frozen plasma or recombinant factor XI may be used, but only if necessary.

Related Chapters

Template:Hematology

Template:WikiDoc Sources